NCT01828164

Brief Summary

To study whether or not the Aevo System™ medical device enhances the rate of tooth movement in human subjects who use orthodontic braces.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2013

Typical duration for not_applicable

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 3, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 10, 2013

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

April 12, 2017

Completed
Last Updated

May 22, 2017

Status Verified

April 1, 2017

Enrollment Period

2.5 years

First QC Date

April 3, 2013

Results QC Date

October 20, 2016

Last Update Submit

April 11, 2017

Conditions

Keywords

OrthodonticsBracesTooth

Outcome Measures

Primary Outcomes (1)

  • Rate of Tooth Movement

    The weekly rate of tooth movement (mm/week) as compared between the treated side and the control side.

    24 weeks or until the extraction space was closed (whichever came first)

Secondary Outcomes (2)

  • Rate of Root Resorption

    24 weeks or until the extraction space was closed (whichever came first)

  • Discomfort

    24 weeks or until the extraction space was closed (whichever came first)

Study Arms (2)

Treatment Arm

EXPERIMENTAL

20 minutes per day of ultrasound treatment on the active side of the device. The device consists of a mouth guard type device with transducers embedded in the mouth guard. In the split mouth design, the treatment arm consist of the side of the mouth with the transducers activated.

Device: Ultrasound

Control Arm

SHAM COMPARATOR

The transducers are not activated on the control side of the device.The subjects wear the device for 20 minutes per day for the duration of the study. The device consists of a mouth guard type device with transducers embedded in the mouth guard. In the split mouth design, the control arm consist of the side of the mouth with the transducers deactivated.

Device: Sham comparator

Interventions

The Aevo System™ is an ultrasound emitting dental device.

Also known as: Aevo System.
Treatment Arm

Ultrasound not activated in the comparator side of the device.20 minutes per day of ultrasound treatment on the active side of the device. The device consists of a mouth guard type device with transducers embedded in the mouth guard. In the split mouth design, the treatment arm consist of the side of the mouth with the transducers activated while the comparator arm has the transducers deactivated.

Control Arm

Eligibility Criteria

Age12 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Subjects who meet all of the following criteria will qualify for entry into the study:
  • Scheduled to receive orthodontic treatment or in early stage of orthodontic treatment
  • Minimum of 3 mm of extraction space (on both sides of a dental arch) to be closed either by distal movement of all 6 anterior teeth from canine to canine or by distal movement of the canines.
  • Available for follow-up visits.
  • Willing and able to sign written informed consent.
  • Healthy.
  • Has permanent dentition and between the ages of 12 and 40.
  • Good oral hygiene and compliance

You may not qualify if:

  • Subjects who meet any of the following criteria will be excluded from the study:
  • Any compromised medical or dental condition that prevents the subject from participating in the trial or using the medical device.
  • Any implanted assistive devices.
  • Currently involved in any other study.
  • Lives significantly outside the clinical trial site.
  • Use of bisphosphonates.
  • Pregnant females .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Site 3: Strathcona Orthodontics Clinic

Edmonton, Alberta, T6E 6E8, Canada

Location

Site 1: University of Alberta, Facilty of Dentistry

Edmonton, Alberta, T6G 2E1, Canada

Location

Site 4: Faculty of Dentistry, University of Manitoba

Winnipeg, Manitoba, R3E 0W2, Canada

Location

Site 5: Dr. Dumore and Team Orthodontics

Winnipeg, Manitoba, R3J 0P1, Canada

Location

Site 2: Faculty of Dentistry, University of Toronto

Toronto, Ontario, M5G 1G6, Canada

Location

MeSH Terms

Conditions

Malocclusion

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Results Point of Contact

Title
John Simon, Regulatory Affairs Manager
Organization
SmileSonica Inc.

Study Officials

  • Tarek El-Bialy, PhD, FRCD(C)

    University of Alberta, Department of Dentistry

    PRINCIPAL INVESTIGATOR
  • Kevin L Knowlton, DDS

    Faculty of Dentistry, University of Toronto

    PRINCIPAL INVESTIGATOR
  • Bryan D Tompson, DDS, FRCD(C)

    Faculty of Dentistry, University of Toronto

    PRINCIPAL INVESTIGATOR
  • Terry Carlyle, DDS, MS

    Strathcona Orthodontics, Edmonton

    PRINCIPAL INVESTIGATOR
  • William Wiltshire, BChD, ChD

    Faculty of Dentistry, University of Manitoba

    PRINCIPAL INVESTIGATOR
  • Tim Dumore, DMD, BS, MS

    Dr. Dumore and Team Orthodontics, Winnipeg

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2013

First Posted

April 10, 2013

Study Start

January 1, 2013

Primary Completion

July 1, 2015

Study Completion

July 1, 2015

Last Updated

May 22, 2017

Results First Posted

April 12, 2017

Record last verified: 2017-04

Locations